Embed Size (px)
Citation preview
PROGRAMME
9
STEMI Live! Friday 26th - Saturday 27th April 2019Radisson Blu Hotel, Nairobi, Kenya
Pre-Congress Workshops (Thursday 25th April 2019)
Imaging 2019! Point of Care Ultrasound
Applied Cardiovascular Intervention Course
ACLS Provider Course (Fully Certified)
Workshop – Improving STEMI care in your hospital
PASCAR/ KCS/ SHS Heart Failure course
FOR MORE INFORMATION & TO REGISTER CONTACTHeart & Life Conferences. The Oval Building.
Tel:+254 (0)721 575 483Email: [email protected]
Website: www.africastemi.com
9
STEMI Live! Friday 26th - Saturday 27th April 2019Radisson Blu Hotel, Nairobi, Kenya
Pre-Congress Workshops (Thursday 25th April 2019)
Imaging 2019! Point of Care Ultrasound
Applied Cardiovascular Intervention Course
ACLS Provider Course (Fully Certified)
Workshop – Improving STEMI care in your hospital
PASCAR/ KCS/ SHS Heart Failure course
FOR MORE INFORMATION & TO REGISTER CONTACTHeart & Life Conferences. The Oval Building.
Tel:+254 (0)721 575 483Email: [email protected]
Website: www.africastemi.com
Day 1 FRIDAY 26th APRIL 2019 MT KENYA 1,2,3
06:30 am
08:30 - 09:45 am
Pre-registered Delegates Registration and Collection Of Lunch Voucher(Mt. ELGON 1)NEWLY REGISTERING DELEGATES – Main Foyer on First floor
11:30 - 12:00 am Tea Break ABSTRACTS LIVE! - ACUTE CORONARY SYNDROMES(in FOYER)
STEMI LIVE! FROM GOA TO MOMBASA
STEMI care as demonstrated
in different settings.
SpeakersHarun Otieno (F), Habib Gamra (F), Mohamed Jeilan (F), Swaleh Misfar,Kieran Mwazo , Arif Varvani,Guruprasad Naik
PanelistsMahmoud Sani, Robert WelshChris Granger, Derek ChinSimon Mwaura, Benjamin WachiraMuthoni Ntonjira,James KayimaAwad Mohamed, Sanjeevkumar Kalkeka
PanelistsMahmoud Sani, Robert WelshChris Granger, Derek ChinSimon Mwaura, Benjamin WachiraMuthoni Ntonjira, James KayimaAwad Mohamed, Bien-Aimé Baraza,Willis Chimano, Savara Mudigi,Polycarp Otieno, Sanjeevkumar Kalkekar
PanelistsChris Granger, David KettlesMzee Ngunga
PanelistsDavid SIlverstein, Mahmood SaniTatizo Shemu
PanelistsMzee Ngunga, Kais Battikh
14:00 - 15:00 pm Lunch ABSTRACTS LIVE! – INTERVENTIONAL CARDIOLOGY
PanelistsMzee Ngunga, Kais Battikh
Time Event
09:45 am Wrap up
10:00 - 10:15 am STEMI news in 2018/9 Ahmed Suliman
10:15 - 10:30 am Drug therapy innovations Harun Otieno
10:30 - 10:45 am Myocardial Infarction Normal Coronary Arteries (MINOCA)Sanjeevkumar Kalkekar
10:45 - 11:00 am Resuscitation innovations Chris Granger
11:00 - 11:30 am ECG innovations Live! Charit Bhograj
PanelistsDerek Chin, Saad Subahi Mohamed Jeilan
12:00 - 12:30 pm STATE OF THE ARTAntiplatelet therapy in ACS: A plethora of choicesRobert Welsh
12:30 - 13:00 pm KEYNOTE PRESENTATION“Wealth and health” –The impact of socioeconomic status on the natural history of CVDBernard Gersh
13:00 - 13:40 pm STATE OF THE ARTImaging 2019 “State of the art”Jeroen Bax
Day 1 FRIDAY 26th APRIL 2019 MT KENYA 1,2,3
15:00 - 15:30 pm PROBLEM SOLVING SESSION - ANTICOAGULATIONMzee Ngunga
18:00 - 18:30 pm Evening Tea Break ABSTRACTS LIVE! – CASE REPORTS
PanelistsFred Bukachi, Nancy KunyihaDaniel Gikonyo
To be determined by panel of judges
PanelistsFred Bukachi
PanelistsChris Granger, Elijah OgolaMzee Ngunga, James KayimaGloria Mukeshimana
PanelistsBernard Gersh, Bernard Gitura
PanelistsDaniel Gikonyo, Adie HorakJamal Nasiruddin, Bernard GershElijah Ogola, Anders Barasa
PanelistsMzee Ngunga, Kais Battikh
Time Event
15:30 - 16:00 pm STATE OF THE ARTThe Apple watch, the LINQ and silent AFChris Granger
16:00 - 16:30 pm PROBLEM SOLVING SESSION HYPERTENSION Harun Otieno
16:30 - 17:00 pm KEY NOTE PRESENTATIONThe resuscitation and return of spontaneous circulation of renaldenervation therapy.Bernard Gersh
17:00 - 17:30 pm PROBLEM SOLVING SESSION DYSLIPIDAEMIAErick Njenga
17:30 - 17:45 pm Wrap upErick Njenga
17:45 - 18:00 pm ImagingPrize winning case
PROGRAM
Day 1 FRIDAY 26th APRIL 2019 MT KENYA 1,2,3
06:30 am
08:30 - 09:45 am
Pre-registered Delegates Registration and Collection Of Lunch Voucher(Mt. ELGON 1)NEWLY REGISTERING DELEGATES – Main Foyer on First floor
11:30 - 12:00 am Tea Break ABSTRACTS LIVE! - ACUTE CORONARY SYNDROMES(in FOYER)
STEMI LIVE! FROM GOA TO MOMBASA
STEMI care as demonstrated
in different settings.
SpeakersHarun Otieno (F), Habib Gamra (F), Mohamed Jeilan (F), Swaleh Misfar,Kieran Mwazo , Arif Varvani,Guruprasad Naik
PanelistsMahmoud Sani, Robert WelshChris Granger, Derek ChinSimon Mwaura, Benjamin WachiraMuthoni Ntonjira,James KayimaAwad Mohamed, Sanjeevkumar Kalkeka
PanelistsMahmoud Sani, Robert WelshChris Granger, Derek ChinSimon Mwaura, Benjamin WachiraMuthoni Ntonjira, James KayimaAwad Mohamed, Bien-Aimé Baraza,Willis Chimano, Savara Mudigi,Polycarp Otieno, Sanjeevkumar Kalkekar
PanelistsChris Granger, David KettlesMzee Ngunga
PanelistsDavid SIlverstein, Mahmood SaniTatizo Shemu
PanelistsMzee Ngunga, Kais Battikh
14:00 - 15:00 pm Lunch ABSTRACTS LIVE! – INTERVENTIONAL CARDIOLOGY
PanelistsMzee Ngunga, Kais Battikh
Time Event
09:45 am Wrap up
10:00 - 10:15 am STEMI news in 2018/9 Ahmed Suliman
10:15 - 10:30 am Drug therapy innovations Harun Otieno
10:30 - 10:45 am Myocardial Infarction Normal Coronary Arteries (MINOCA)Sanjeevkumar Kalkekar
10:45 - 11:00 am Resuscitation innovations Chris Granger
11:00 - 11:30 am ECG innovations Live! Charit Bhograj
PanelistsDerek Chin, Saad Subahi Mohamed Jeilan
12:00 - 12:30 pm STATE OF THE ARTAntiplatelet therapy in ACS: A plethora of choicesRobert Welsh
12:30 - 13:00 pm KEYNOTE PRESENTATION“Wealth and health” –The impact of socioeconomic status on the natural history of CVDBernard Gersh
13:00 - 13:40 pm STATE OF THE ARTImaging 2019 “State of the art”Jeroen Bax
Day 1 FRIDAY 26th APRIL 2019 MT KENYA 1,2,3
15:00 - 15:30 pm PROBLEM SOLVING SESSION - ANTICOAGULATIONMzee Ngunga
18:00 - 18:30 pm Evening Tea Break ABSTRACTS LIVE! – CASE REPORTS
PanelistsFred Bukachi, Nancy KunyihaDaniel Gikonyo
To be determined by panel of judges
PanelistsFred Bukachi
PanelistsChris Granger, Elijah OgolaMzee Ngunga, James KayimaGloria Mukeshimana
PanelistsBernard Gersh, Bernard Gitura
PanelistsDaniel Gikonyo, Adie HorakJamal Nasiruddin, Bernard GershElijah Ogola, Anders Barasa
PanelistsMzee Ngunga, Kais Battikh
Time Event
15:30 - 16:00 pm STATE OF THE ARTThe Apple watch, the LINQ and silent AFChris Granger
16:00 - 16:30 pm PROBLEM SOLVING SESSION HYPERTENSION Harun Otieno
16:30 - 17:00 pm KEY NOTE PRESENTATIONThe resuscitation and return of spontaneous circulation of renaldenervation therapy.Bernard Gersh
17:00 - 17:30 pm PROBLEM SOLVING SESSION DYSLIPIDAEMIAErick Njenga
17:30 - 17:45 pm Wrap upErick Njenga
17:45 - 18:00 pm ImagingPrize winning case
PROGRAM Parallel Session
Day 1 FRIDAY 26th APRIL 2019 MT ELGON 1,2
INTERVENTION LIVE!Live! From London UK
18:00 - 18:30 pm EVENING TEA BREAKABSTRACTS LIVE! – CASE REPORTS
PanelistsNashwa Ahmed, Martin Murage, Tatizo Shemu, James Kayima, Anthony Gikonyo
PanelistsCharles Kariuki, Parag PatelJonathan Byrne
PanelistsAdie Horak, Samir AhniaJonathan Byrne, Rob WelshPrem Ponoth, Robert Mathenge
PanelistsDerek Chin, Robert WelshHabib Gamra, Nashwa Ahmed
PanelistsMzee Ngunga, Kais Battikh
CORONARY INTERVENTION
Time Event
15:00 - 16:00 pm
Aortic Valve Replacement Transcatheter and underlocal anaesthetic Live andin 1 hour
STATE OF THE ARTImaging in structural interventionJeroen Bax
16:30 - 17:30 pm
16:00 - 16:30 pm
The Panafrican Course on InterventionalCardiology (PAFCIC)- 20th Anniversary. Instructive cases.Habib Gamra, Kais BattikhMohamed Jeilan
17:30 - 17:45 pm INTERVENTIONPrize winning caseKais Battikh
Wrap upAnthony Gikonyo
17:45 - 18:00 pm
SpeakersJonathan ByrneMohamed JeilanDerek Chin
Day 2 SATURDAY 27th APRIL 2019 MT KENYA 1,2,3
07:30 am
08:30 - 09:00 am
Registration
10:30 - 11:00 am Tea BreakABSTRACTS LIVE! – HEART FAILURE AND VALVULAR HEART DISEASE
STATE OF THE ART Individualised care for Heart FailureJohn McMurray
PanelistsSelma Mohamed, Mahmoud SaniAlan Fraser, Hussein Bagha,Samuel Okechukwu Ogah, Mary Kiarie,Jaimini Gohil, Roseanne Nyabera
PanelistsYagoub Musa, Habib GamraCharles Kariuki, David KettlesSalim Hassanali
PanelistsDavid Kettles, Alice MuthoniFred Bukachi, Thomas Menge,Robert Imbui
PanelistsMzee Ngunga, Kais Battikh
14:00 - 15:00 pm Lunch ABSTRACTS LIVE! – GENERAL CARDIOLOGY
PanelistsMzee Ngunga, Kais Battikh
Time Event
09:00 - 09:30 am Interactive session - Heart failure as a multidisciplinary diseaseDavid Kettles
09:30 - 09:45 am Heart failure – Acute HF management strategiesDerek Chin
09:45 - 10:00 am Heart failure – Acute cardiogenic shock. Principles and drug options and mechanical support strategieJonathan Byrne
10:00 - 10:15 am LV assist devices and transplantsSelma Mohammed
10:15 - 10:30 am DiscussionGerald Yonga
PanelistsJonathan Byrne, Mohamed JeilanPeter Ogutu, Jeroen Bax
11:00 - 11:30 pm KEY NOTE PRESENTATIONAdherence and compliance - why people do not take drugs that workChris Granger
11:30 - 11:45 pm DiscussionAhmed Suliman
11:45 - 12:15 pm STATE OF THE ARTValve interventions for heart failure. State of the ArtRobert Welsh
PanelistsDavid Kettles, Selma MohammedElijah Ogola, Mahmood Sani
12:15 - 13:00 pm KEY NOTE PRESENTATIONWhat to expect in Heart Failure in the next two to three yearsJohn McMurray
PROGRAM Parallel Session
Day 1 FRIDAY 26th APRIL 2019 MT ELGON 1,2
INTERVENTION LIVE!Live! From London UK
18:00 - 18:30 pm EVENING TEA BREAKABSTRACTS LIVE! – CASE REPORTS
PanelistsNashwa Ahmed, Martin Murage, Tatizo Shemu, James Kayima, Anthony Gikonyo
PanelistsCharles Kariuki, Parag PatelJonathan Byrne
PanelistsAdie Horak, Samir AhniaJonathan Byrne, Rob WelshPrem Ponoth, Robert Mathenge
PanelistsDerek Chin, Robert WelshHabib Gamra, Nashwa Ahmed
PanelistsMzee Ngunga, Kais Battikh
CORONARY INTERVENTION
Time Event
15:00 - 16:00 pm
Aortic Valve Replacement Transcatheter and underlocal anaesthetic Live andin 1 hour
STATE OF THE ARTImaging in structural interventionJeroen Bax
16:30 - 17:30 pm
16:00 - 16:30 pm
The Panafrican Course on InterventionalCardiology (PAFCIC)- 20th Anniversary. Instructive cases.Habib Gamra, Kais BattikhMohamed Jeilan
17:30 - 17:45 pm INTERVENTIONPrize winning caseKais Battikh
Wrap upAnthony Gikonyo
17:45 - 18:00 pm
SpeakersJonathan ByrneMohamed JeilanDerek Chin
Day 2 SATURDAY 27th APRIL 2019 MT KENYA 1,2,3
07:30 am
08:30 - 09:00 am
Registration
10:30 - 11:00 am Tea BreakABSTRACTS LIVE! – HEART FAILURE AND VALVULAR HEART DISEASE
STATE OF THE ART Individualised care for Heart FailureJohn McMurray
PanelistsSelma Mohamed, Mahmoud SaniAlan Fraser, Hussein Bagha,Samuel Okechukwu Ogah, Mary Kiarie,Jaimini Gohil, Roseanne Nyabera
PanelistsYagoub Musa, Habib GamraCharles Kariuki, David KettlesSalim Hassanali
PanelistsDavid Kettles, Alice MuthoniFred Bukachi, Thomas Menge,Robert Imbui
PanelistsMzee Ngunga, Kais Battikh
14:00 - 15:00 pm Lunch ABSTRACTS LIVE! – GENERAL CARDIOLOGY
PanelistsMzee Ngunga, Kais Battikh
Time Event
09:00 - 09:30 am Interactive session - Heart failure as a multidisciplinary diseaseDavid Kettles
09:30 - 09:45 am Heart failure – Acute HF management strategiesDerek Chin
09:45 - 10:00 am Heart failure – Acute cardiogenic shock. Principles and drug options and mechanical support strategieJonathan Byrne
10:00 - 10:15 am LV assist devices and transplantsSelma Mohammed
10:15 - 10:30 am DiscussionGerald Yonga
PanelistsJonathan Byrne, Mohamed JeilanPeter Ogutu, Jeroen Bax
11:00 - 11:30 pm KEY NOTE PRESENTATIONAdherence and compliance - why people do not take drugs that workChris Granger
11:30 - 11:45 pm DiscussionAhmed Suliman
11:45 - 12:15 pm STATE OF THE ARTValve interventions for heart failure. State of the ArtRobert Welsh
PanelistsDavid Kettles, Selma MohammedElijah Ogola, Mahmood Sani
12:15 - 13:00 pm KEY NOTE PRESENTATIONWhat to expect in Heart Failure in the next two to three yearsJohn McMurray
PROGRAM
Day 2 SATURDAY 27th APRIL 2019 MT KENYA 1,2,3
PanelistsElijah Ogola, Chris GrangerJames Kayima, John McMurrayBernard Gersh, Ahmed SulimanRobert Welsh, Abraham Siika
PanelistsGerald Yonga, Felix Barasa
PanelistsMartin Murage
Time Event14:00 - 14:30 pm
14:30 - 15:45 pm Cardiovascular research challenges in Africa.RoundtableGerald Yonga, Felix Barasa
15:45 - 16:00 pm Cardiovascular research challenges in AfricaA suggested roadmapGerald Yonga
16:00 - 16:30 pm
16:30 pm
KEY NOTE PRESENTATION“From CREOLE to infinity” Lessons in African healthcare researchElijah Ogola
KEY NOTE PRESENTATIONClinical trials and tribulations, registries and confounders“Things may not always be as they seem”Bernard Gersh
Best research and case report prize and awardMzee Ngunga
PROGRAM
Day 2 SATURDAY 27th APRIL 2019 MT KENYA 1,2,3
PanelistsElijah Ogola, Chris GrangerJames Kayima, John McMurrayBernard Gersh, Ahmed SulimanRobert Welsh, Abraham Siika
PanelistsGerald Yonga, Felix Barasa
PanelistsMartin Murage
Time Event14:00 - 14:30 pm
14:30 - 15:45 pm Cardiovascular research challenges in Africa.RoundtableGerald Yonga, Felix Barasa
15:45 - 16:00 pm Cardiovascular research challenges in AfricaA suggested roadmapGerald Yonga
16:00 - 16:30 pm
16:30 pm
KEY NOTE PRESENTATION“From CREOLE to infinity” Lessons in African healthcare researchElijah Ogola
KEY NOTE PRESENTATIONClinical trials and tribulations, registries and confounders“Things may not always be as they seem”Bernard Gersh
Best research and case report prize and awardMzee Ngunga
Faculty List
Abraham Siika Kenya
Adrian Horak South Africa
Ahmed Suliman Sudan
Alan Fraser UK
Alice Muthoni Kenya
Anders Barasa Kenya
Anthony Gikonyo Kenya
Arif Varvani Kenya
Awad Mohamed Sudan
Benjamin Wachira Kenya
Bernard Gersh USA
Bernard Gitura Kenya
Charit Bhograj India
Charles Kariuki Kenya
Chris Granger USA
Constantine Akwanalo Kenya
Daniel Gikonyo Kenya
David Kettles South Africa
David Silverstein Kenya
Derek Chin Singapore
Elijah Ogola Kenya
Eric Njenga Kenya
Etienne Amendezo Kenya
Felix Barasa Kenya
Fred Bukachi Kenya
Gerald Yonga Kenya
Gloria Mukeshimana Rwanda
Guruprasad Naik India
Habib Gamra Tunisia
Harun Otieno Kenya
Hassan Adan Kenya
Hussein Bagha Kenya
Jamal Nasiruddin Tanzania
James Kayima Uganda
Jeroen Bax Netherlands
John McMurray UK
Jonathan Byrne UK
Jose Roberto Angola
Justiaan Swannevelder South Africa
Kais Battikh Tunisia
Kieran Mwazo Kenya
Mahmood Sani Nigeria
Martin Murage Kenya
Mohamed Jeilan Kenya
Muthoni Ntonjira Kenya
Mzee Ngunga Kenya
Nancy Kunyiha Kenya
Nashwa Ahmed Sudan
Parag Patel USA
Prem Ponoth Kenya
Robert Mathenge Kenya
Robert Welsh Canada
Roseanne Nyabera Kenya
Salim Hassanali Kenya
Samir Ahnia Algeria
Samuel Okechukwu Nigeria
Sanjeev Kalkekar India
Selma Mohamed USA
Sheila Omangathe Kenya
Swaleh Misfar Kenya
Tatizo Shemu Tanzania
Yacoub Musa Sudan
Yemi Johnson Nigeria
*FORXIGA™ is not indicated for the management of weight loss or high blood pressure. Weight loss was a secondary endpoint in clinical trials. References: 1. Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus statement by the American Association of clinical endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm – 2017 executive summary. Endocrine Practice 2017;23(2):207-238. 2. IMS Health Database, MIDAS August 2015. 3. Rosenstock J, Hansen L, Zee P, et al. Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin. Diabetes Care 2015;38(3):376-383. 4. Bailey CJ, Gross JL, Pieters A, et al. Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial. Lancet 2010;375:2223-2233. 5. Sjöström CD, Johansson P, Ptaszynska A, et al. Dapagliflozin lowers blood pressure in hypertensive and non-hypertensive patients with type 2 diabetes. Diab Vasc Dis Res 2015;12(5):352-358. FORXIGA™ 5 mg, 10 mg Film-coated Tablets. Each 5 mg and 10 mg tablet contains dapagliflozin propanediol monohydrate equivalent to 5 mg and 10 mg dapagliflozin respectively. Excipient with known effect: Each 5 mg and 10 mg tablet contains 25 mg and 50 mg of lactose anhydrous respectively. PHARMACEUTICAL FORM: Film-coated tablet. THERAPEUTIC INDICATIONS: FORXIGA™ is indicated in adults aged 18 years and older with type 2 diabetes mellitus to improve glycaemic control as monotherapy or add-on combination therapy. For full prescribing information refer to the Standard Export Leaflet approved by the medicines regulatory authority. AstraZeneca Pharmaceuticals (Pty) Ltd. Reg. No. 1992/005854/07. Building 2, Northdowns Office Park, 17 Georgian Crescent West, Bryanston, South Africa, 2191. Private Bag X23, Bryanston, South Africa, 2021. Tel: +27 (0) 11 797-6000. Fax: +27 (0) 11 797-6001. www.astrazeneca.com. FORXIGA™ is a registered trademark of the AstraZeneca group of companies. Expiry Date: January 2021. Activity ID: XS-1553.
The World’s Most Prescribed SGLT2i2
GLUCOSE OUT1
LIFE INHbA1c reduction1,3,4
A glucosuric effect that results in:1
With the additional benefits of:
Weight loss*1,4 Blood pressure reduction*1,5
ON
E TABLET
ONCE A D
AY
Superior HbA1c reduction vs. a DPP4i as dual add-on to metformin3
TM
1A PG 6 FOR ALL CLAIMS
4A PG 22233A PG 376
4B PG 2229 5A PG 352
3A PG 376
1A PG 6
SEE DOC
Image guided therapy
Azurion 7
With Azurion,performance and superior care become one
*FORXIGA™ is not indicated for the management of weight loss or high blood pressure. Weight loss was a secondary endpoint in clinical trials. References: 1. Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus statement by the American Association of clinical endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm – 2017 executive summary. Endocrine Practice 2017;23(2):207-238. 2. IMS Health Database, MIDAS August 2015. 3. Rosenstock J, Hansen L, Zee P, et al. Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin. Diabetes Care 2015;38(3):376-383. 4. Bailey CJ, Gross JL, Pieters A, et al. Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial. Lancet 2010;375:2223-2233. 5. Sjöström CD, Johansson P, Ptaszynska A, et al. Dapagliflozin lowers blood pressure in hypertensive and non-hypertensive patients with type 2 diabetes. Diab Vasc Dis Res 2015;12(5):352-358. FORXIGA™ 5 mg, 10 mg Film-coated Tablets. Each 5 mg and 10 mg tablet contains dapagliflozin propanediol monohydrate equivalent to 5 mg and 10 mg dapagliflozin respectively. Excipient with known effect: Each 5 mg and 10 mg tablet contains 25 mg and 50 mg of lactose anhydrous respectively. PHARMACEUTICAL FORM: Film-coated tablet. THERAPEUTIC INDICATIONS: FORXIGA™ is indicated in adults aged 18 years and older with type 2 diabetes mellitus to improve glycaemic control as monotherapy or add-on combination therapy. For full prescribing information refer to the Standard Export Leaflet approved by the medicines regulatory authority. AstraZeneca Pharmaceuticals (Pty) Ltd. Reg. No. 1992/005854/07. Building 2, Northdowns Office Park, 17 Georgian Crescent West, Bryanston, South Africa, 2191. Private Bag X23, Bryanston, South Africa, 2021. Tel: +27 (0) 11 797-6000. Fax: +27 (0) 11 797-6001. www.astrazeneca.com. FORXIGA™ is a registered trademark of the AstraZeneca group of companies. Expiry Date: January 2021. Activity ID: XS-1553.
The World’s Most Prescribed SGLT2i2
GLUCOSE OUT1
LIFE INHbA1c reduction1,3,4
A glucosuric effect that results in:1
With the additional benefits of:
Weight loss*1,4 Blood pressure reduction*1,5
ON
E TABLET
ONCE A D
AY
Superior HbA1c reduction vs. a DPP4i as dual add-on to metformin3
TM
1A PG 6 FOR ALL CLAIMS
4A PG 22233A PG 376
4B PG 2229 5A PG 352
3A PG 376
1A PG 6
SEE DOC
Image guided therapy
Azurion 7
With Azurion,performance and superior care become one
Our Partners
Please continue to support and take an interest in cardiovascular research in Africa by attending (1) the moderated abstract sessions at AfricaSTEMI Live! and (2) the popular and interactive “Research in Cardiovascular disease” roundtable discussion on Saturday afternoon.
Abstracts will be presented by the corresponding author or an assigned colleague during the exhibition breaks during dedicated moderated sessions according to the subjects below.
1. Coronary artery disease and ACS – general (Session 1, Friday morning 1130am)
2. Interventional cardiology (session 2, Friday afternoon 2pm)3. Case reports (session 3, Friday afternoon, 6pm)4. Heart failure and valvular heart disease (Session 4, Saturday
morning 1030am)5. General cardiology (Session 5, Saturday afternoon 2pm)
This year has seen a huge number of abstracts submitted from across the continent. Abstracts were received from Algeria, Cameroon, Congo, Cote D’Ivoire, Egypt, Ethiopia, Kenya, Mali, Morocco, Rwanda, Sudan, Tanzania, Uganda, South Africa and Tunisia. All accepted abstracts have been simultaneously published in a special AfricaSTEMI supplementary edition of the Cardiovascular Journal of Africa, the journal of PASCAR and sub-Saharan Africa’s highest impact factor cardiovascular journal. Abstracts were graded according to local relevance, originality and extent of data preparation.
Abstract Review Committee. The peer review process has involved a peer review team lead by:
1. Dr Ahmed Suliman (Sudan)2. Dr Kais Battikh (Tunisia3. Ahmed Suliman (Sudan)4. Awad Mohamed (Sudan)5. Habib Gamra (Tunisia)6. Kais Battikh (Tunisia)7. Martin Murage (Kenya)8. Mohamed Jeilan (Kenya)9. Mpiko Ntsekhe (South Africa)10. Mzee Ngunga (Kenya)
Research and Abstracts @ Africa STEMI Live
Training villages @ AfricaSTEMI Live!
Alongside the plenary Scientific sessions are parallel training villages in which a specific skill will be transferred to participants of AfricaSTEMI. The training villages will invite participants during the pre-congress workshop and during the exhibition breaks. This year we are pleased to announce five skill transfer stations across the africaSTEMI training villages.
1. Point of Care Ultrasound. Hands-on session. This will be held at the Phillips Training village on Friday 26th April. This session will be for POCUS congress attendees and will involve hands-on scanning of real patients with clinical pathology. An additional session will be held at the GE Healthcare training village.
2. How to perform PCI. This will be held at the Boston Scientific training village on Friday 26th April and Saturday 27th April. A wet model has been flown in from South Africa. Participants will be able to learn hand skills and tips and tricks for performing percutaneous coronary intervention including wire exchange techniques and guide catheter and balloon delivery.
3. How to thrombolyse. This will be held at the GE training village on Friday 26th April. Participants will be shown how to perform a 12 lead ECG, transmit to a dedicated ECG diagnosis team, and make decisions on performance of thrombolysis including assessment of indications and contraindications and types of agents.
4. Stress ECG testing. This will be held at the GE training village on Saturday 27th April. Participants will be shown how to perform and interpret stress ECG testing.
5. Coronary physiology. This will be held at the Phillips training village on Saturday 27th April.
Attendees at the pre-congress workshops will be given priority but bookings will be strictly on a first-come, first-served basis. To book a place at any of the training villages, please visit the Phillips, Boston Scientific, and GE booths for a dedicated slot.
Notes
